stockrowNautilus Biotechnology, Inc. (NAUT) vs ARS Pharmaceuticals, Inc. (SPRY)
- Nautilus Biotechnology, Inc. NAUT 2.23 +3.72%
- ARS Pharmaceuticals, Inc. SPRY 2.79 +5.28%
Nautilus Biotechnology, Inc. and ARS Pharmaceuticals, Inc. are both Biotechnology companies. Nautilus Biotechnology, Inc. and ARS Pharmaceuticals, Inc. are of similar size ($273.9M and $263.5M). Across the 10 metrics below, Nautilus Biotechnology, Inc. leads on 6 and ARS Pharmaceuticals, Inc. on 4.
Valuation
Profitability
| Metric | NAUT | SPRY | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 0.00% | 68.51% |
| Operating margin | 0.00% | (161.50%) | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | (149.89%) | 0.00% |
| Return on equity | (41.01%) | 0.00% | (51.96%) |
| Return on assets | (33.49%) | 0.00% | (46.06%) |
| Return on invested capital | (133.48%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack